Mukaltin-LekT (MUCALTIN-LEK T)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

1 tablet contains:

Active substance: mukaltin (althea medicinal herb extract dry) extract dry with the content of the sum of polysaccharides in terms of glucose 18% - 50 mg.

Excipients: acid wine - 160 mg, sodium hydrogen carbonate - 87 mg, calcium stearate - 3 mg.

Description:

Tablets are round-shaped, planocylindrical with a facet and a risk on one side, from light gray to brownish-gray, with impregnations of darker or lighter particles.

Pharmacotherapeutic group:Expectorant of plant origin
ATX: & nbsp
  • Expectorants
    • Pharmacodynamics:

    Mukaltin is a mixture of polysaccharides from the herb althea medicinal, possesses expectorant properties.

    Thanks to reflex stimulation, it intensifies the activity of the ciliated epithelium and the peristalsis of respiratory bronchioles in combination with increased secretion of the bronchial glands.

    Pharmacokinetics:Data on the pharmacokinetics of the drug are absent.
    Indications:

    Acute and chronic diseases of the respiratory tract, accompanied by a cough with the formation of difficult-to-detachable sputum of increased viscosity (including tracheobronchitis, obstructive bronchitis, bronchiectasis, pneumonia) - as part of complex therapy.

    Contraindications:Hypersensitivity to the components of the drug; peptic ulcer of the stomach and duodenum; glucose-galactose malabsorption; children under 12 years.
    Pregnancy and lactation:

    Application during pregnancy and during breastfeeding is possible on the recommendation of a doctor.

    Dosing and Administration:

    In adults and children over 12 years of age inside 1-2 tablets 2-3 times a day before meals. When used in children, the tablet can be dissolved in 1/3 cup of warm water. The average course of treatment is 7-14 days.

    Side effects:

    Allergic reactions, dyspepsia.

    Overdose:To date, cases of overdose have not been reported.
    Interaction:

    Mucaltin can be prescribed concomitantly with other drugs used in the treatment of bronchopulmonary diseases.

    Mucaltin should not be used concomitantly with drugs containing codeine and other antitussive medicines, as this makes it difficult for the diluted sputum to escape.

    Special instructions:Before taking the drug, you should consult your doctor.
    Effect on the ability to drive transp. cf. and fur:

    The drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Form release / dosage:Pills.
    Packaging:

    For 10 tablets in a contour non-cellular package of paper with a polymer coating or in a flexible packaging of multi-layer composite materials "Buflen".

    For 10 tablets in a contour mesh package made of polyvinyl chloride film EP-73 and aluminum foil printed lacquered.

    1, 2, 3 contour non-jammed packages or contour mesh packages together with the instruction for use are placed in a pack of cardboard for consumer containers.

    By 600 contour non-jammed packages with an equal number of instructions for use are placed directly in the group package.

    Storage conditions:

    In the dark place at a temperature of 8 ° C to 15 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-001591
    Date of registration:16.03.2012 / 20.06.2017
    Expiration Date:Unlimited
    The owner of the registration certificate:Tyumen Chemical - Pharmaceutical Plant, OJSC Tyumen Chemical - Pharmaceutical Plant, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp20.05.2018
    Illustrated instructions
      Instructions
      Up